Hypocapnic Cerebral Hypoperfusion: The POTS Mechanism Nobody Is Talking About

If you've spent any time in the POTS world, you've heard the usual story. Heart rate goes up when you stand. Blood pools in your legs. Take salt, wear compression, maybe try a beta blocker. And for a lot of people, none of that really moves the needle. The reason is straightforward: that story is incomplete. It treats the heart rate as the problem instead of asking what's actually happening upstream.

There's a mechanism that researchers at Harvard's Brigham and Women's Hospital have now characterized in detail — one that sits underneath both POTS and a large group of patients who don't even meet POTS criteria but have the same symptoms. It's called hypocapnic cerebral hypoperfusion, and it may be the most important concept in orthostatic intolerance that most patients have never heard of.

What Is Hypocapnic Cerebral Hypoperfusion?

Hypocapnic cerebral hypoperfusion (HYCH): a measurable reduction in blood flow to the brain caused by abnormally low carbon dioxide levels in the blood, typically occurring or worsening when a person stands up. It produces the same symptoms as POTS — brain fog, dizziness, fatigue, cognitive dysfunction — but does not require an elevated heart rate to be present.

Let's break the name down. Hypo means low. Capnic refers to carbon dioxide (CO2). Cerebral means brain. Hypoperfusion means not enough blood flow. String it together: low CO2 is causing your brain to not get enough blood.

That matters because CO2 isn't just a waste gas you breathe out. It's one of the most powerful regulators of blood vessel diameter in the brain. When CO2 levels drop, the arteries in the brain constrict. Tighten up. And when those arteries constrict, less blood gets through — regardless of what your heart rate or blood pressure is doing.

This isn't speculation. It's measurable with two tools: a transcranial Doppler ultrasound (which tracks blood flow velocity in the brain's arteries in real time) and a capnograph (which measures the CO2 in your exhaled breath). Put those together during a tilt test, and you can watch it happen.

Notice what's missing from that chain. Heart rate. Blood pressure. Neither one has to change for this entire cascade to play out. That's why so many people feel terrible when they stand up, go get tested, and hear: "Your vitals look fine."

What Does the Research Actually Show?

In October 2024, Dr. Peter Novak and colleagues at Brigham and Women's Hospital (Harvard Medical School) published a study in Frontiers in Neurology that changed the picture. They screened 3,327 patients and studied 127 with HYCH, 125 with POTS, and 42 healthy controls. The title says it plainly: "Orthostatic intolerance with tachycardia (POTS) and without (HYCH) represent a spectrum of the same disorder" (Novak et al., Frontiers in Neurology, 2024).

The findings were striking. Not subtle. Not ambiguous.

The two groups — POTS and HYCH — were statistically indistinguishable on nearly every measure that matters. Same symptom duration. Same female predominance. Same autonomic complaints. Same supine and standing norepinephrine levels. Same inflammatory markers. Same rates of small fiber neuropathy. Both showed reduced cerebral blood flow velocity on tilt. Both showed reduced end-tidal CO2.

The only real difference? Whether or not the body compensated with a heart rate jump of 30 beats per minute or more. If it did, you got the POTS label. If it didn't, you got told your tests were normal — despite having the exact same underlying problem.

Read that again. The tachycardia in POTS isn't the disease. It's the brain's attempt to compensate for a blood flow problem. Your heart rate is literally trying to save the day — and we've been treating it as the villain.

POTS and HYCH Are the Same Disorder

Here's where it gets uncomfortable for the current diagnostic framework. The Novak study didn't just find similarities between these two groups. It concluded they sit on a single spectrum of the same pathology — separated only by whether the body mounts a tachycardic response. The shared mechanism underneath both: reduced orthostatic cerebral blood flow driven by hypocapnia-induced vasoconstriction.

Think about what that means clinically. A patient walks into a cardiology office. Tilt table. Heart rate goes up 35 beats. POTS diagnosis. Treatment plan: beta blocker, salt, fluids, compression stockings.

A different patient — same symptoms, same brain fog, same inability to stand in a grocery store line — walks into the same office. Tilt table. Heart rate goes up 22 beats. "You don't have POTS. Your tests are normal." Sent home.

Both patients have the same problem. The same cerebral hypoperfusion. The same low CO2. The same mechanism. One just happened to compensate with enough tachycardia to cross an arbitrary threshold, and the other didn't. We are separating a single disorder into two buckets based on a number that describes the compensation, not the disease.

Why Does CO2 Drop in the First Place?

The hypocapnia doesn't come out of nowhere. It comes from hyperventilation — but not the dramatic, paper-bag, panic-attack kind. We're talking about something much more subtle. Chronic. Usually completely imperceptible to the person doing it.

When you stand up and your brain senses that blood flow is about to drop, it can trigger a compensatory respiratory shift. You breathe a little faster. A little deeper. Maybe you sigh more frequently. You're not panicking — your brainstem is running a reflex. But the net result is that CO2 gets exhaled faster than your metabolism produces it, and levels fall.

Dr. Novak's earlier research, published in PLOS ONE in 2018, established hypocapnic cerebral hypoperfusion as a measurable biomarker of orthostatic intolerance (Novak, PLOS ONE, 2018). In that study, over 70% of patients with chronic fatigue syndrome showed hypocapnia during tilt testing, and more than 90% showed cerebral hypoperfusion.

The CO2 drop itself has multiple potential drivers. Dysregulated respiratory control from the brainstem. Abnormal chemoreflex sensitivity. Chronic pain states that subtly alter breathing patterns. Post-viral changes that affect central respiratory pacemakers. And critically — proprioceptive errors in the cervical spine and vestibular system that feed incorrect position data to the brainstem, corrupting the autonomic response to standing.

That last one is where things get clinically interesting, because it's addressable. If the brainstem is receiving garbled input about where the head is in space, it can't coordinate the multi-system response that standing requires. Fix the input, and the brainstem can organize the output more efficiently.

Why Standard Treatment Misses This

Most POTS treatment targets blood volume or heart rate. Salt. Fluids. Compression. Beta blockers. Midodrine. Fludrocortisone. These aren't necessarily wrong — they're incomplete. They're treating downstream consequences while the upstream mechanism keeps running.

Consider what happens with a beta blocker. The heart rate was going up for a reason — to maintain blood pressure so the brain could get some perfusion. Block that response, and yes, the palpitations and anxiety may settle down because you've closed the sympathetic feedback loop. But the cerebral blood flow problem is still there. For some patients, it gets worse, because you just removed the one compensation their body had left.

This isn't to say these medications are never useful. Some patients need them as a bridge while the underlying regulation is being addressed. But using them without measuring what's actually happening in the brain is flying blind.

What Needs to Be Measured

If this mechanism is as central as the data suggests, the diagnostic question shifts. Instead of asking "Does your heart rate go up by 30 beats?" we should be asking: What is happening to the blood flow in your brain when you stand up?

Three measurements matter:

Cerebral blood flow velocity (CBFv): measured with transcranial Doppler ultrasound during a controlled tilt. This shows, in real time, whether your brain's blood supply drops when you go from lying down to upright. A decline of more than 20% is clinically significant.

End-tidal CO2 (EtCO2): measured with capnography during the same tilt. Normal resting EtCO2 is roughly 35–45 mmHg. Values dropping below 30 mmHg on standing point directly to the hypocapnic mechanism.

Cerebrovascular reactivity: how well the blood vessels in the brain respond to changes in CO2 and blood pressure. This isn't a single number — it involves looking at autoregulation (the reflex that keeps brain blood flow stable), neurovascular coupling (blood delivery to active neurons), and vasomotor reactivity (how brain arteries respond to CO2 changes).

Standard tilt table testing that only tracks heart rate and arm blood pressure misses all of this. It's like diagnosing an engine problem by only checking the speedometer.

The Comorbidity Pattern Makes Sense Now

One of the more frustrating aspects of POTS and dysautonomia is that they rarely travel alone. The same patients show up with overlapping diagnoses that, on the surface, seem unrelated. The Novak 2024 data puts numbers to what clinicians have observed for years — and the overlap between POTS and HYCH patients was nearly identical:

Data: Novak et al., Frontiers in Neurology, 2024 — Table 2

Look at those numbers. The overlap isn't just similar — it's practically the same population. And that starts to make sense when you view these conditions through the lens of central regulation rather than isolated diagnoses.

The brain doesn't have separate control panels for mood, digestion, pain processing, and blood pressure. The brainstem nuclei that regulate autonomic output are physically adjacent to the systems that modulate pain sensitivity, gastrointestinal motility, immune regulation, and emotional processing. They share circuitry. They influence each other constantly.

When the central regulatory machinery isn't working efficiently, you don't get one problem. You get a cluster. And the cluster looks like: dysautonomia + anxiety + IBS + headaches + brain fog + pain — the exact patient profile that keeps showing up.

The Novak study also found that the majority of both POTS and HYCH patients met criteria for central sensitization syndrome — a state where the central nervous system amplifies sensory signals, producing heightened pain, sensory sensitivity, and fatigue. This isn't a psychiatric finding. It's a neurological one, and it's consistent with a brain that isn't getting adequate perfusion and is operating in a state of chronic resource scarcity.

What Treatment Looks Like When You Target the Mechanism

So if the actual problem is reduced cerebral blood flow — driven by dysregulated CO2, corrupted sensory input, and upstream coordination errors — you have to go after those things. Suppressing the outputs or masking the compensations doesn't solve anything. It just makes the numbers on the monitor look less alarming while the brain stays starved.

In our clinic, this looks like a layered assessment first. We identify where in the regulatory chain the breakdown is occurring: Is it the brainstem's respiratory control? Vestibular input that's corrupting autonomic coordination? Cervical proprioceptive error that's feeding bad data to the balance and blood flow regulation systems? Impaired neurovascular coupling from a prior concussion or viral insult?

Then we build a targeted rehabilitation protocol. Not a generic exercise plan. Specific inputs calibrated to the nervous system's current capacity:

• Respiratory integration. We don't coach you to breathe differently on purpose. We target the central integration so your breathing naturally recalibrates to match metabolic demand — producing stable CO2 levels without you having to think about it.
• Vestibular rehabilitation to recalibrate the sensory inputs your brainstem relies on when coordinating blood pressure regulation during position changes.
• Cervical proprioceptive work. The neck feeds critical position data to the brainstem. If that signal is corrupted, autonomic and vascular regulation both suffer. We clean up the input.
• Oculomotor exercises — specific eye movement patterns that drive brainstem circuits directly involved in autonomic control.
• Graded tilt oscillation — progressive postural challenges that retrain the baroreceptor and cerebrovascular reflexes over time.

We're not trying to manage your symptoms for life. We're trying to get your nervous system back to a place where standing in line at a grocery store, cooking dinner, or going for a walk doesn't require heroic effort from your cardiovascular system. And we track it objectively — transcranial Doppler and capnography before, during, and after — because we don't guess. We watch the numbers move.

We see this pattern regularly in our clinic. A patient comes in after being told their tilt test was normal. We add transcranial Doppler monitoring and find a 35% drop in cerebral blood flow velocity on tilt — with perfectly stable arm blood pressure. Their end-tidal CO2 is sitting at 26 mmHg. The dysautonomia symptoms that "didn't have an explanation" suddenly have a measurable, targetable mechanism.

Who Gets Missed?

About half of all orthostatic intolerance patients — based on the Novak data — don't produce enough tachycardia to cross the POTS threshold. They have the same cerebral hypoperfusion, the same symptom burden, the same inability to function. But they fall through every diagnostic net because the one number everyone fixates on (heart rate) doesn't spike high enough to trigger a diagnosis.

These patients get told some version of:

• "Your tilt test was normal."
• "It might be anxiety."
• "Try drinking more water."
• "We don't see anything wrong."

The problem isn't that nothing is wrong. The problem is that nobody measured the right thing. If you only check heart rate and arm blood pressure during a tilt test, you are physically incapable of detecting hypocapnic cerebral hypoperfusion. It doesn't show up in those numbers. You need transcranial Doppler and capnography, and most tilt labs don't use them.

If you've been through the standard workup, been told your tests are normal, but you can barely stand in your kitchen without your brain shutting down — you're not crazy. The testing was incomplete.

The 120 BPM Question

One detail that helps put all of this in context: the resting rate of the human heart — with no brain input at all — is approximately 120 beats per minute. That's where the heart wants to sit on its own. Your brain uses parasympathetic output (the vagus nerve, primarily) to slow it down to a normal resting rate of 60–80 bpm.

When someone with POTS goes from 70 to 120 on standing, what you're seeing is parasympathetic withdrawal. The brakes came off. The brain let go of its slowing influence, and the heart drifted back toward its natural rate. That's a different physiology than going from 70 to 140 or 150, where sympathetic drive is actively pushing the gas pedal.

This distinction matters for treatment. A patient who is losing parasympathetic tone needs a fundamentally different intervention than one whose sympathetic system is flooding the circuit. But if you don't understand the mechanism, they look the same on a tilt table — "heart rate went up." The difference between the brakes coming off and the gas being slammed is invisible if you're only reading the speedometer.

What You Can Do Right Now

A few things you can do without waiting for anyone's permission:

1. Track your CO2. Consumer-grade capnographs exist. During a standard at-home orthostatic test (lie down for 5 minutes, then stand), note whether your end-tidal CO2 drops below 30 mmHg on standing. This is not diagnostic by itself, but it's a useful screening signal.

2. Request transcranial Doppler during tilt testing. If you're getting a formal tilt table test, ask whether the lab includes TCD monitoring. Most don't. If they don't, the test cannot detect HYCH. A normal result on a standard tilt test does not rule out cerebral hypoperfusion.

3. Pay attention to your breathing patterns. Do you sigh frequently? Breathe through your mouth? Feel like you can't get a full breath even though your oxygen saturation is fine? These are clues to chronic hyperventilation that may be driving hypocapnia.

4. Question the "it's just anxiety" framing. The Novak 2024 data showed that 68–76% of POTS and HYCH patients had anxiety diagnoses. But anxiety and hyperventilation-driven cerebral hypoperfusion produce nearly identical symptoms: racing heart, dizziness, air hunger, cognitive impairment. The difference is that one is a psychological interpretation and the other is a measurable physiological state. Both may be present. But the physiology should be measured before the psychology is assumed.

5. Get the right evaluation. A practitioner who understands this mechanism will measure cerebral blood flow, CO2 dynamics, and autonomic regulation — not just heart rate and blood pressure. That's the evaluation that can actually identify what's driving your symptoms.

Dr. Keiser is a board-certified chiropractic neurologist (DC, DACNB, FABBIR), not a medical doctor (MD/DO). This content is for educational purposes and does not constitute medical advice. It is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific situation. Medication decisions should be made with your prescribing physician.

← Back to Blog